Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytokine-induced Killer Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT02482454
What this trial is testing

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
The First People's Hospital of Changzhou 50
Early research (Phase 1)UnknownNCT03282435
What this trial is testing

Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 Antibody

Who this might be right for
Non-small Cell Lung Cancer
Dalian University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT02490735
What this trial is testing

CIK in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First People's Hospital of Changzhou 2,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT04836728
What this trial is testing

Phase II Study of Chemotherapy and PD-1 Inhibitor Combination With Autologous CIK Cell Immunotherapy to Treat Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer MetastaticFirst-line Treatment
Tianjin Medical University Cancer Institute and Hospital 156
Not applicableLooking for participantsNCT05676190
What this trial is testing

Clinical Study on the Efficacy of Autologous Cell Factor Induced Killer Cells in the Treatment of Colorectal Cancer

Who this might be right for
Colorectal Cancer
ShiCang Yu 80
Testing effectiveness (Phase 2)Looking for participantsNCT05869279
What this trial is testing

Allogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic Leukemia

Who this might be right for
B-cell NHLCLL
Fondazione Matilde Tettamanti Menotti De Marchi Onlus 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT02490748
What this trial is testing

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
The First People's Hospital of Changzhou 10
Very early researchLooking for participantsNCT06643221
What this trial is testing

Exercise as an Immune Adjuvant for Allogeneic Cell Therapies

Who this might be right for
LeukemiaHematopoetic Stem Cell TransplantationDonor Lymphocyte Infusion+3 more
University of Arizona 200
Testing effectiveness (Phase 2)UnknownNCT02644863
What this trial is testing

Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer

Who this might be right for
Esophageal NeoplasmsNeoplasmsDigestive System Neoplasms+1 more
Shenzhen Hornetcorn Bio-technology Company, LTD 60
Large-scale testing (Phase 3)UnknownNCT04292769
What this trial is testing

Clinical Study of DC-CIK Cells as a Post-remission Treatment for Malignant Tumors

Who this might be right for
Malignant Neoplasm
Li Yu 200
Testing effectiveness (Phase 2)Study completedNCT01186809
What this trial is testing

Cytokine Induced Killer (CIK) Cells In Leukemia Patients

Who this might be right for
Hematologic Malignancies
A.O. Ospedale Papa Giovanni XXIII 74
Testing effectiveness (Phase 2)UnknownNCT02688673
What this trial is testing

DC Vaccine Combined With CIK Cells in Patients With SCLC

Who this might be right for
Small- Cell Lung Cancer
Affiliated Hospital to Academy of Military Medical Sciences 30
Testing effectiveness (Phase 2)Ended earlyNCT01871480
What this trial is testing

CIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Kunming Medical University 50
Testing effectiveness (Phase 2)UnknownNCT01924156
What this trial is testing

DC Vaccine Combined With CIK Cells in Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Affiliated Hospital to Academy of Military Medical Sciences 30
Testing effectiveness (Phase 2)UnknownNCT02886897
What this trial is testing

Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors

Who this might be right for
Hepatocellular CarcinomaRenal Cell CarcinomaBladder Cancer+3 more
Sun Yat-sen University 50
Early research (Phase 1)UnknownNCT03987867
What this trial is testing

Study of Autologous CIK Cell Immunotherapy Combination With PD-1 Inhibitor and Chemotherapy in the Advanced NSCLC

Who this might be right for
Non-small Cell Lung CancerFirst-line Treatment
Tianjin Medical University Cancer Institute and Hospital 30
Early research (Phase 1)Looking for participantsNCT06321484
What this trial is testing

Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer

Who this might be right for
Platinum-resistant Ovarian CancerRecurrent Ovary CancerOvarian Cancer+4 more
Dana-Farber Cancer Institute 18
Early research (Phase 1)Looking for participantsNCT07011004
What this trial is testing

Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

Who this might be right for
Acute Myeloid Leukemia RefractoryAcute Myeloid Leukemia, in Relapse
Memorial Sloan Kettering Cancer Center 18
Testing effectiveness (Phase 2)UnknownNCT01898663
What this trial is testing

DCs Vaccine Combined With Cytokine-induced Killer Cells in Patients With AML

Who this might be right for
High-risk Soft Tissue Sarcoma
Affiliated Hospital to Academy of Military Medical Sciences 30
Large-scale testing (Phase 3)UnknownNCT05955157
What this trial is testing

Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal AdenocarcinomaAdvanced Solid Tumor
University of Malaya 52
Next Page